Skip to main content
Have a personal or library account? Click to login
Genetic alteration in melanoma development Cover

Genetic alteration in melanoma development

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 63 (2009): Issue 3 (June 2009)
By: ,  ,   and    
Open Access
|Nov 2009
References

References

  1. Balch, C.M., Buzaid, A.C., Soong, S.J., Atkins, M.B., Cascinelli, N., Coit, D.G., Fleming, I.D., Gershenwald, J.E., Houghton, A., Jr., Kirkwood, J.M., McMasters, K.M., Mihm, M.F., Morton, D.L., Reintgen, D.S., Ross, M.I., Sober, A., Thompson, J.A., Thompson. J.F. (2001). Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.,(16), 3635-3648.
    Open DOISearch in Google Scholar
  2. Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., Sampas, N., Dougherty, E., Wang, E., Marincola, F., Gooden, C., Lueders, J., Glatfelter, A., Pollock, P., Carpten, J., Gillanders, E., Leja, D., Dietrich, K., Beaudry, C., Berens, M., Alberts, D., Sondak, V. (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling.,(6795), 536-540.
    Search in Google Scholar
  3. Blackwood, M. A., Holmes, R., Synnestvedt, M., Young, M., George, C., Yang, H., Elder D. E., Schuchter, L. M., Guerry, D., Ganguly, A. (2002). Multiple primary melanoma revisited.,(8), 2248-2255.
    Open DOISearch in Google Scholar
  4. Byrd, K.M., Wilson, D.C., Hoyler, S.S., Peck, G.L. (2004). Advanced presentation of melanoma in African Americans.,(1), 142-143.
    Open DOISearch in Google Scholar
  5. Clark, W.H. Jr., Elder, D.E., Guerry, D. 4, Epstein, M.N., Greene, M.H., Van Horn, M. (1984). A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma.,(12), 1147-1165.
    Open DOISearch in Google Scholar
  6. Curtin, J.A., Fridlyand, J., Kageshita, T., Patel, H.N., Busam, K.J., Kutzner, H., Cho, K.H., Aiba, S., Brocker, E.B., LeBoit, P.E., Pinkel, D., Bastian, B.C. (2005). Distinct sets of genetic alterations in melanoma.,(20), 2135-2147.
    Open DOISearch in Google Scholar
  7. Danen, E.H., Ten Berge, P.J., Van Muijen, G.N., Van't Hof-Grootenboer, A.E., Brocker, E.B., Ruiter, D.J. (1994). Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression.,(3), 249-256.
    Open DOISearch in Google Scholar
  8. Daniotti, M., Oggionni, M., Ranzani, T., Vallacchi, V., Campi, V., Di Stasi, D., Torre, G.D., Perrone, F., Luoni, C., Suardi, S., Frattini, M., Pilotti, S., Anichini, A., Tragni, G., Parmiani, G., Pierotti, M.A., Rodolfo, M. (2004).alterations are associated with complex mutational profiles in malignant melanoma.,(35), 5968-5977.
    Open DOISearch in Google Scholar
  9. Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B.A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G.J., Bigner, D.D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J.W., Leung, S.Y., Yuen, S.T., Weber, B.L., Seigler, H.F., Darrow, T.L., Paterson, H., Marais, R., Marshall, C.J., Wooster, R., Stratton, M.R., Futreal, P.A. (2002). Mutations of thegene in human cancer.,(6892), 949-954.
    Search in Google Scholar
  10. de Snoo, F.A., Hayward, N.K. (2005). Cutaneous melanoma susceptibility and progression genes.,(2), 153-186.
    Open DOISearch in Google Scholar
  11. Demunter, A., Stas, M., Degreef, H., De Wolf-Peeters, C., van den Oord, J.J. (2001). Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma.,(6), 1483-1489.
    Open DOISearch in Google Scholar
  12. Dhawan, P., Singh, A.B., Ellis, D.L., Richmond, A. (2002). Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression.,(24), 7335-7342.
    Search in Google Scholar
  13. Diepgen, T.L., Mahler, V. (2002). The epidemiology of skin cancer.,(Suppl. 61), 1-6.
    Open DOISearch in Google Scholar
  14. Du, J., Miller, A.J., Widlund, H.R., Horstmann, M.A., Ramaswamy, S., Fisher, D.E. (2003). MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.,(1), 333-343.
    Open DOISearch in Google Scholar
  15. Duncan, L.M., Deeds, J., Cronin, F.E., Donovan, M., Sober, A.J., Kauffman, M., McCarthy, J.J. (2001). Melastatin expression and prognosis in cutaneous malignant melanoma.,(2), 568-576.
    Open DOISearch in Google Scholar
  16. Edwards, R.H., Ward, M.R., Wu, H., Medina, C.A., Brose, M.S., Volpe, P., Nussen-Lee, S., Haupt, H.M., Martin, A.M., Herlyn, M., Lessin, S.R., Weber, B.L. (2004). Absence ofmutations in UV-protected mucosal melanomas.,(4), 270-272.
    Open DOISearch in Google Scholar
  17. Felding-Habermann, B., Fransvea, E., O'Toole, T.E., Manzuk, L., Faha, B., Hensler, M. (2002). Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.,(5), 427-436.
    Open DOISearch in Google Scholar
  18. Garbe, C., McLeod, G.R., Buettner, P.G. (2000). Time trends of cutaneous melanoma in Queensland, Australia and Central Europe.,, 1269-1278.
    Open DOISearch in Google Scholar
  19. Garraway, L.A., Widlund, H.R., Rubin, M.A., Getz, G., Berger, A.J., Ramaswamy, S., Beroukhim, R., Milner, D.A., Granter, S.R., Du, J., Lee, C., Wagner, S.N., Li, C., Golub, T.R., Rimm, D.L., Meyerson, M.L., Fisher, D.E., Sellers, W.R. (2005). Integrative genomic analyses identifyas a lineage survival oncogene amplified in malignant melanoma.,(7047), 117-122.
    Search in Google Scholar
  20. Goldstein, A.M., Chan, M., Harland, M., Hayward, N.K., Demenais, F., Timothy Bishop, D., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., Calista, D., Cannon Albright, L.A., Chaudru, V., Chompret, A., Cuellar, F., Elder, D.E., Ghiorzo, P., Gillanders, E.M., Gruis, N.A., Hansson, J., Hogg, D., Holland, E.A., Kanetsky, P.A., Kefford, R.F., Teresa Landi, M., Lang, J., Leachman, S.A., Mackie, R.M., Magnusson, V., Mann, G.J., Newton Bishop, J., Palmer, J.M., Puig, S., Puig-Butille, J.A., Stark, M., Tsao, H., Tucker, M.A., Whitaker, L., Yakobson, E. (2007). Features associated with germlinemutations: a GenoMEL study of melanoma-prone families from three continents.,(2), 99-106.
    Open DOISearch in Google Scholar
  21. Gorden, A., Osman, I., Gai, W., He, D., Huang, W., Davidson, A., Houghton, A.N., Busam, K., Polsky, D. (2003). Analysis ofandmutations in metastatic melanoma tissues.,(14), 3955-3957.
    Search in Google Scholar
  22. Gray-Schopfer, V.C., Cheong, S.C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z.A., Marais, R., Wynford-Thomas, D., Bennett, D.C. (2006). Cellular senescence in naevi and immortalisation in melanoma: A role for p16?,(4), 496-505.
    Open DOISearch in Google Scholar
  23. Hammock, L., Cohen, C., Carlson, G., Murray, D., Ross, J.S., Sheehan, C., Nazir, T.M., Carlson, J.A. (2006). Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with recurrent melanoma.,(9), 599-607.
    Open DOISearch in Google Scholar
  24. Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B.L., Federman, S., Miller, J.R. 3, Allen, R.E., Singer, M.I., Leong, S.P., Ljung, B.M., Sagebiel, R.W., Kashani-Sabet, M. (2005). The gene expression signatures of melanoma progression.,(17), 6092-6097.
    Open DOISearch in Google Scholar
  25. Hofmann, U.B., Westphal, J.R., Waas, E.T., Becker, J.C., Ruiter, D.J., van Muijen, G.N. (2000) Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression.,(4), 625-632.
    Open DOISearch in Google Scholar
  26. Hornberg, J.J., Bruggeman, F.J., Westerhoff, H.V., Lankelma, J. (2006). Cancer: A Systems Biology disease.,(2-3), 81-90.
    Open DOISearch in Google Scholar
  27. Hsu, M.Y., Meier, F.E., Nesbit, M., Hsu, J.Y., Van Belle, P., Elder, D.E., Herlyn, M. (2000a). E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.,(5), 1515-1525.
    Open DOISearch in Google Scholar
  28. Hsu, M., Andl, T., Li, G., Meinkoth, J.L., Herlyn, M. (2000b). Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression.,(Pt 9), 1535-1542.
    Open DOISearch in Google Scholar
  29. Jiveskog, S., Ragnarsson-Olding, B., Platz, A., Ringborg, U. (1998). N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin.,(5), 757-761.
    Open DOISearch in Google Scholar
  30. Kumar, R., Angelini, S., Snellman, E., Hemminki, K. (2004).mutations are common somatic events in melanocytic nevi.,(2), 342-348.
    Open DOISearch in Google Scholar
  31. Li, X., Regezi, J., Ross, F.P., Blystone, S., Ilic, D., Leong, S.P., Ramos, D.M. (2001). Integrin alphavbeta3 mediates K1735 murine melanoma cell motilityand,(Pt 14), 2665-2672.
    Open DOISearch in Google Scholar
  32. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M., Eng, C., Parsons, R. (1997). Germline mutations of thegene in Cowden disease, an inherited breast and thyroid cancer syndrome.,(1), 64-67.
    Open DOISearch in Google Scholar
  33. Miller, A.J., Mihm, M.C. Jr. (2006). Melanoma.,(1), 51-65.
    Open DOISearch in Google Scholar
  34. Ortega, S., Malumbres, M., Barbacid, M. (2002). Cyclin D-dependent kinases, INK4 inhibitors and cancer.,(1), 73-87.
    Open DOISearch in Google Scholar
  35. Papp, T., Pemsel, H., Zimmermann, R., Bastrop, R., Weiss, D.G., Schiffmann, D. (1999). Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi.,(8), 610-614.
    Search in Google Scholar
  36. Petitelerc, E., Stromblad, S., von Schalscha, T.L., Mitjans, F., Piulats, J., Montgomery, A.M., Cheresh, D.A., Brooks, P.C. (1999). Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.,(11), 2724-2730.
    Search in Google Scholar
  37. Pollock, P.M., Harper, U.L., Hansen, K.S., Yudt, L.M., Stark, M., Robbins, C.M., Moses, T.Y., Hostetter, G., Wagner, U., Kakareka, J., Salem, G., Pohida, T., Heenan, P., Duray, P., Kallioniemi, O., Hayward, N.K., Trent, J.M., Meltzer, P.S. (2003). High frequency ofmutations in nevi.,(1), 19-20.
    Open DOISearch in Google Scholar
  38. Poynter, J.N., Elder, J.T., Fullen, D.R., Nair, R.P., Soengas, M.S., Johnson, T.M., Redman, B., Thomas, N.E., Gruber, S.B. (2006).andmutations in melanoma and melanocytic nevi.,(4), 267-273.
    Open DOISearch in Google Scholar
  39. Reifenberger, J., Knobbe, C.B., Sterzinger, A.A., Blaschke, B., Schulte, K.W., Ruzicka, T., Reifenberger, G. (2004). Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.,(3), 377-384.
    Open DOISearch in Google Scholar
  40. Rhodes, A.R., Weinstock, M.A., Fitzpatrick, T.B., et al. (1987). Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals.,(21), 3146-3154.
    Open DOISearch in Google Scholar
  41. Rodolfo, M., Daniotti, M., Vallacchi, V. (2004). Genetic progression of metastatic melanoma.,(2), 133-147.
    Open DOISearch in Google Scholar
  42. Rusciano, D. (2000). Differentiation and metastasis in melanoma.,(2), 147-163.
    Search in Google Scholar
  43. Saldanha, G., Purnell, D., Fletcher, A., Potter, L., Gillies, A., Pringle, J.H. (2004). Highmutation frequency does not characterize all melanocytic tumor types.,(5), 705-710.
    Open DOISearch in Google Scholar
  44. Sasaki, Y., Niu, C., Makino, R., Kudo, C., Sun, C., Watanabe, H., Matsunaga, J., Takahashi, K., Tagami, H., Aiba, S., Horii, A. (2004).point mutations in primary melanoma show different prevalences by subtype.,(1), 177-183.
    Open DOISearch in Google Scholar
  45. Sharpless, N.E., DePinho, R.A. (2005). Cancer: Crime and punishment.,(7051), 636-637.
    Search in Google Scholar
  46. Stahl, J.M., Sharma, A., Cheung, M., Zimmerman, M., Cheng, J.Q., Bosenberg, M.W., Kester, M., Sandirasegarane, L., Robertson, G.P. (2004). Deregulated Akt3 activity promotes development of malignant melanoma.,(19), 7002-7010.
    Open DOISearch in Google Scholar
  47. Takeuchi, H., Kuo, C., Morton, D.L., Wang, H.J., Hoon, D.S. (2003). Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.,(2), 441-448.
    Search in Google Scholar
  48. Thomas, N.E., Alexander, A., Edmiston, S.N., Parrish, E., Millikan, R.C., Berwick, M., Groben, P., Ollila, D.W., Mattingly, D., Conway, K. (2004). Tandemmutations in primary invasive melanomas.,(5), 1245-1250.
    Open DOISearch in Google Scholar
  49. Tsao, H., Goel, V., Wu, H., Yang, G., Haluska, F.G. (2004). Genetic interaction betweenandmutations andinactivation in melanoma.,(2), 337-341.
    Open DOISearch in Google Scholar
  50. Tsao, H., Zhang, X., Fowlkes, K., Haluska, F.G. (2000). Relative reciprocity ofandalterations in cutaneous melanoma cell lines., 60(7), 1800-1804.
    Search in Google Scholar
  51. Uribe, P., Wistuba, I.I., Gonzalez, S. (2003).mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin.,(5), 365-670.
    Open DOISearch in Google Scholar
  52. van Elsas, A., Zerp, S.F., van der Flier, S., Kruse, K.M., Aarnoudse, C., Hayward, N.K., Ruiter, D.J., Schrier, P.I. (1996). Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.,(3), 883-893.
    Search in Google Scholar
  53. Williams, M.L., Sagebiel, R.W. (1994). Melanoma risk factors and atypical moles.,(4), 343-350.
    Search in Google Scholar
  54. Wu, H., Goel, V., Haluska, F.G. (2003). PTEN signaling pathways in melanoma.,(20), 3113-3122.
    Open DOISearch in Google Scholar
  55. Yazdi, A.S., Palmedo, G., Flaig, M.J., Puchta, U., Reckwerth, A., Rutten, A., Mentzel, T., Hugel, H., Hantschke, M., Schmid-Wendtner, M.H., Kutzner, H., Sander, C.A. (2003). Mutations of thegene in benign and malignant melanocytic lesions.,(5), 1160-1162.
    Open DOISearch in Google Scholar
  56. Zhang, Y., Xiong, Y., Yarbrough, W.G. (1998). ARF promotes MDM2 degradation and stabilizes p53:locus deletion impairs both the Rb and p53 tumor suppression pathways.,(6), 725-734.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10046-009-0029-2 | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 73 - 80
Published on: Nov 6, 2009
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Keywords:
cancer,
melanoma,
genes,
mutations,
genetics
Related subjects:
Mathematics,
General mathematics

© 2009 Dace Pjanova, Kristīne Azarjana, Ingrīda Čēma, Olita Heisele, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.

Volume 63 (2009): Issue 3 (June 2009)
Next article